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Abstract 
The “anomalous solubility behavior at higher pH values” of several acidic drugs originally studied by 
Higuchi et al. in 1953 [1], but hitherto not fully rationalized, has been re-analyzed using a novel solubility-
pH analysis computer program, pDISOL-X
TM
. The program internally derives implicit solubility equations, 
given a set of proposed equilibria and constants (iteratively refined by weighted nonlinear regression), and 
does not require explicit Henderson-Hasselbalch equations. The re-analyzed original barbital, 
phenobarbital, oxytetracycline, and sulfathiazole solubility-pH data of Higuchi et al. is consistent with the 
presence of dimers in saturated solutions.  In the case of barbital, phenobarbital and sulfathiazole, anionic 
dimers, reaching peak concentrations near pH 8. However, oxytetracycline indicated a pronounced 
tendency to form a cationic dimer, peaking near pH 2.  Under the conditions of the original study, only 
barbital indicated a slight tendency to form a salt precipitate at pH > 6.8, with a highly unusual 




 + 3HA  KA5H4(s).  Thus the 
“anomaly” in the Higuchi data can be rationalized by invoking specific aggregated species.   
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Introduction 
Aggregation and micelle formation of drugs in a saturated solution can complicate the interpretation of 
the solubility measurements, especially when the molecules are ionizable.  There are many reports of such 
systems [1-6].  For example, doxycycline [3], with intrinsic solubility S0 = 0.72 mg/mL, at 25
oC in 1 M 
NaCl/HCl solutions (pH 0 to 6), forms dimers with K2 = 24 M
-1.  Such aggregates were found to have 
unusually high and temperature-sensitive solubility. Zhu and Streng [4] found that the self-association of 
dolasetron to form cationic dimers and trimers was enthalpy driven (H-bond/aromatic ring rather than 
hydrophobic/electrostatic interactions), with the aggregation constants, K2-3, ranging from 4 to 50 M
-1 at 
25oC. Many nonsteroidal antiinflammatory drugs [5], such as indomethacin, diclofenac, ibuprofen, 
ketoprofen, naproxen, and sulindac, can self-associate by forming mixed-charge micelle or micelle-like 
structures. The reported CMC of diclofenac is about 25 mM and of ketoprofen is about 160 mM [5]. The 
solubility-pH profiles cannot be accurately described with the Henderson-Hasselbalch equation when 
aggregates form [2,6]. 
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     The objective of this brief commentary is to address the “anomalous solubility behavior at higher pH 
values” of several ionizable drugs studied by Higuchi et al. in 1953 [1], but hitherto not fully understood. 
The measured solubility-pH profiles of two barbiturates (phenobarbital, barbital) and two ampholytes 
(oxytetracycline and sulfathiazole) showed anomalous shapes, which could not be accurately described by 
the Henderson-Hasselbalch equations.  Analysis of the data using a new program, pDISOL-X, suggested the 
presence of anionic (mixed-charge) dimers, AHA
-
, in the case of the barbiturates and sulfathiazole and very 
stable cationic (mixed-charge) dimers, XH2∙XH3
+
, in the case of oxytetracycline. Higuchi et al. noted that 
between pH 6.8 and 7.1, the slope in the log S vs. pH plot for barbital had a value of +0.55, but no concrete 
explanation was offered. They also noted the oxytetracycline between pH 2 and 5 had a slope of -0.91, 
which would not have been expected for a simple system.  The values of the pKa of the molecules were not 
reported in the study.  Had accurate pKa values been discussed, then other anomalies in the solubility data 
would have been evident at that time. 
Experimental  
Legacy Data 
In the Higuchi et al. study [1], pH was adjusted by the addition of standardized HCl or KOH to buffer-free 
suspensions containing 10-30 % excess solid over the saturation concentration.  The ionic strength was well 
controlled with 0.15 M KCl, and the temperature was maintained at 25 °C (30 °C in one case).  The 
equilibration times ranged from one to eight days, after which the final pH had been measured. 
Refinement of Intrinsic and Salt Solubility and Aggregation Constants 
Detail of the mathematical approach in the pDISOL-X computer program has been described by Völgyi 
et al. [6].  Briefly, the new data analysis method uses log S - pH as measured input data from any analytical 
technique (along with standard deviations, SD(log S)) into pDISOL-X.  An algorithm was developed which 
considers the contribution of all species proposed to be present in solution, including universal buffer 
components (e.g., Britton-Robinson). The approach does not depend on any explicitly derived extensions 
of the Henderson-Hasselbalch equations. The computational algorithm derives its own implicit equations 
internally, given any practical number of equilibria and estimated constants, which are subsequently 
refined by weighted nonlinear least-squares regression [2,6]. Therefore, in principal, drug-salt precipitates, 
-aggregates, -complexes, - bile salts, -surfactant can be accommodated [2,6]. Presence of specific buffer-
drug species can be tested.  The program assumes an initial condition of a suspension of the solid drug in a 
solution, ideally with the suspension saturated over a wide range of pH. The program calculates the 
distribution of species consequent to a sequence of additions of standardized strong-acid titrant HCl (or 
weak-acid titrants H3PO4, H2SO4, acetic acid, maleic acid, lactic acid) to simulate the suspension pH-
speciation down to pH ~ 0, the staging point for the subsequent operation. A sequence of perturbations 
with standardized KOH is simulated, and solubility calculated at each point (in pH steps of 0.005-0.2), until 
pH ~ 13 is reached. The ionic strength is rigorously calculated at each step, and pKa values (as well as 
solubility products, aggregation and complexation constants) are accordingly adjusted [6].   
At the end of the pH-speciation simulation, the calculated log S vs. pH curve is compared to measured 
log S vs. pH. A log S-weighted nonlinear least squares refinement commences to refine the proposed 
equilibrium model, using analytical expressions for the differential equations. The process is repeated until 
the differences between calculated and measured log S values reach a minimum, as described elsewhere in 
detail [2,6]. 
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Results and Discussion 
 The results of the analysis of the Higuchi et al. data are summarized in Table 1. All four drugs in the 
Higuchi study indicated the presence of singly-charged dimers in saturated solution of the free acid. A salt 
precipitate also formed in the case of barbital.   
Table 1. Summary of the Results of the Re-Analysis of the Higuchi et al. [1] Data. 
COMPOUND 
pKa                   
(25
o
C, I =0.15 M) 
a

















 2.17 ± 0.03 148 ± 10 0.12 




 2.43 ± 0.04 269 ± 22 0.22 




 3.42 ± 0.07 2634 ± 425 0.75 




 1.50 ± 0.10 32 ± 7 0.12 
a
 pKa values taken from the  "Wiki-pKa" database: <http://www.in-adme.com/wiki_pka.php/>. 
b









The solid curve in Figure 1a is the log S vs. pH profile of barbital at 30 °C. The dashed curve in the figure 
was calculated using the Henderson-Hasselbalch equation, employing pKa of 7.86. As can be seen, the 
latter equation does not predict the experimental points very well.  
Figure 1b shows the simulated titration curve (volume of 1 M KOH added per mL of suspension solution 
vs. pH) for barbital that best describes the Higuchi data (discrete points). The amount of solid barbital 
added to 1 mL of water was taken as 250 mg in the pDISOL-X data analysis. The flat region centered at pH 
6.82, bounded by two discontinuities, is due to the co-precipitates of free acid, HA(s), and complex salt, 
KA5H4(s), i.e., [K
+ (HA)3 AHA
-](s). This fixed-pH region is defined by the so called pKa
GIBBS [7,8]. The free acid is 
the only precipitate present for pH < pKa
GIBBS. It takes about 0.3 mL KOH titrant to convert the free acid 
precipitate entirely into the salt form, as shown in Figure 1b. For pH > pKa
GIBBS
, KA5H4(s) is the sole 
precipitate, up to the peak pH 9.56, where the salt precipitate completely dissolves due to ionization 
leading to the formation of the anion, A- (Fig. 1d). Note that the width of the flat region of the titration 
curve (Fig. 1b), and hence the  values of the pKa
GIBBS and peak pH are conditional, since the extent of dimer 
formation depends on the amount of solid added to water. Under the conditions of the study, only barbital 
appeared to show a tendency to form a salt precipitate, consistent with the very unusual stoichiometry 
(slope of +0.55 in the log S-pH plot): KA5H4(s)  K
+ + AHA- + 3HA, with Ksp = 2.23 x10
-8 M5. 
The above salt stoichiometry best rationalizes the log S – pH curve of barbital for pH > pKa
GIBBS. The 
solubility curve (solid line) for pH < pKa
GIBBS 
(6.82) is horizontally displaced to lower pH by about one unit, 
without change in its shape, compared to that calculated using the Henderson-Hasselbalch equation 
(dashed line in Fig. 1a). This is consistent with the formation of a mixed-charge dimeric species, AHA- (in 
the saturated solution), which may be visualized as a conjugate of a free acid, HA, and the ionize species, A- 
(cf., Appendix). The AHA- dominates in concentration over that of A- up to pH 9 (Fig. 1c). For pH > pKa
GIBBS, 
the log S curve takes on a slope of about +0.55, as originally noted by Higuchi et al.  This can be explained if 
a new precipitate replaces HA(s). A reasonable choice might have been K+∙AHA-(s), since AHA- is the 
dominant anion present in solution. However, the log S curve is not well fitted with such a model. Further 
testing of the data could have assumed that the above salt precipitate also contained HA components.  
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After a trial-and-error process, the best fit was found where three molecules of the free acid, HA, and one 
molecule of AHA
-
 combine with K
+
 to form the putative solid with the unusual stoichiometry 
K+(HA)3AHA
-(s). pDISOL-X can easily consider new tentative species in the model development and quickly 
test the data against such species, without having to derive explicit new solubility equations. The method 
described in the Appendix A in [6] certainly could have been applied here to derive the explicit equation 




(s), but the resultant equation would have been quite 
complex and of limited general applicability. 
Figure 1c shows the direct concentration of various barbital species as a function of pH, while Figure 1d 
illustrates the log concentration vs pH relationships. In alkaline solution, the monomeric species, A-, and 
the mixed-charge dimeric species, AHA- coexist, with the latter species reaching a maximum concentration 
at the peak pH 9.56 (Fig. 1c) and declining in concentration with further increases in pH. 
 
Under the conditions of the Higuchi data, of the four compounds studied, only barbital indicated a  
     The above case study of barbital is an example of a general methodology to rationalize complicated 
log S - pH profiles. In a simple “Henderson-Hasselbalch” precipitation process, the log S curve does not 
depend on the quantity of solid added, as long as enough solid is added to maintain a saturated solution.  
However, if an aggregate, oligomer, or micelle-like drug forms, then the measured solubility can critically 
depend on the amount of solid added to solution. For example, suppose a micelle of the drug forms above 
the critical micelle concentration (CMC). A very poorly soluble drug can become better (self-) solubilized in 
high concentration (>CMC). For example, this could explain why a parenteral formulation of amiodarone 
(high concentration) can stop atrial fibrillation in a few minutes post injection, whereas an oral formulation 
may take 30 days to reach full therapeutic effectiveness [9]. Being able to quantitate such concentration 
dependence (due to aggregate formation, etc.) could be a practically useful feature of pDISOL-X in drug 
Figure 1.  Barbital: (a) log S vs. pH; (b) titration curve; (c) concentration of species as a function of pH; (d) log 
concentration of species as a function of pH. 
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development, to help predict dosing effects of poorly soluble molecules which form aggregates in solution. 
Phenobarbital 
Phenobarbital, which is about eight times less soluble than barbital, shows a similar solubility-pH profile 
in Figure 2a as that of barbital, except that no salt precipitate forms (the ratio of the octanol-water 
partition coefficients of the two molecules is also about eight). A dimeric species of the same stoichiometry 
forms as in the case of barbital, reaching maximum concentration at (conditional) pH of 7.82, as shown in 
Figure 2b (the pH-speciation simulation assumed the 5 mg of solid had been added to 1 mL of water). The 
presence of the dimer is indicated by the shift of the log S – pH profile to the lower pH values above pH 5, 






Oxytetracycline is an ampholyte, whose ionizations can be described by three pKa values (Table 1).  
Figure 3a shows the solubility-pH curve shifted to higher pH values below pH 5, compared to what is 
predicted by the Henderson-Hasselbalch equation. This is a pattern consistent with the presence of a 
cationic dimer formed from the neutral XH2 species and the cation XH3
+.  Many other shift patterns have 
been described in reference [2]. The cationic dimer maximized in concentration at (conditional) pH 1.63, as 
shown in Figure 3b (the pH-speciation simulation assumed that 50 mg of solid had been added to 1 mL of 
water). 
Figure 2.  Phenobarbital: (a) log S vs. pH; (b) concentration of species as a function of pH. 





The ampholyte sulfathiazole has the least tendency to form dimers, as suggested in Figure 4. A small 
quantity of anionic dimer appears to be consistent with the high precision data, whose concentration 
reaches a maximum at pH 8.16.  Invoking the presence of a dimeric species under the circumstance would 




  In the pDISOL-X analysis, the “anomaly” in the Higuchi et al. 1953 data could be explained by presence 
of anionic dimers in three cases, and by the strong presence of a cationic dimer in the case of 
oxytetracycline, and also by the barbital salt precipitate that exhibits the slope of +0.55.  Apparently, these 
species were either not recognized originally, or were not fully characterized.  Such anomalies can be 
common with sparingly-soluble drugs, but are not always easy to recognize.  pDISOL-X could be a helpful 
new tool to further aid in the analysis of dissolution mechanisms of sparingly-soluble drugs, since 
dissolution is closely linked to solubility.  
 
Figure 3.  Oxytetracycline: (a) log S vs. pH; (b) concentration of species as a function of pH. 
Figure 4.  Sulfathiazole: (a) log S vs. pH; (b) concentration of species as a function of pH. 
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Appendix 
Shape Pattern Interpretation in Solubility Profiles for Sparingly-Soluble Ionizable Weak Acids 
An important part of the analysis of solubility profiles involves recognizing characteristic shapes and 
interpreting these in terms of an equilibrium model [2]. Figure 5 shows the results of a series of simulations 
of a weak acid, MW 500 g/mol, having the same pKa = 7 and pS0 = 3, but having different combinations of 
salt and aggregate formations. In the first frame, 50 mg of solid free acid were added to 1 mL of 0.15 M KCl 
solution. In the rest of the frames, 1500 mg were added. The calculated average ionic strength is indicated 
in red at the bottom right of each frame. The dashed curves in the figures are calculated from the 
Henderson-Hasselbalch equation using the pKa and pS0 constants. The solid lines are the actual log S curves, 
where either the free acid or the salt is precipitated.  The pH at which both the free acid and the salt co-
precipitate is the pKa
GIBBS 
(Figs. 5b-d).  In cases where pH is raised past the point where the entire solid 




     Figure 5a is the simplest case, with no salt precipitate and no aggregates. The Henderson-Hasselbalch 
equation describes the log S – pH profile as long as the solution remains saturated.  Figures 5b-d show the 
shape of the profiles as K+A-(s) or K+AHA-(s) salts precipitate for pH ≥ pKa
GIBBS. Notice that in Figure 5c, the 
maximum solubility does not occur at pH = pKa
GIBBS. In older literature, it had been popular to refer to 
pKa
GIBBS as “pHmax”, but clearly, such nomenclature is misleading in some cases, such as when complex salts 
form, as in Figure 5c [7,8]. In Figures 5d-f cases, aggregates form, which elevates solubility in characteristic 
ways. In the case of neutral aggregates (Fig. 5d), the region of the intrinsic solubility (pH < pKa) is raised due 
to the enhanced solubility of the neutral species. The apparent pKa is shifted to 8.4 from the true value of 
7. In the cases of charged aggregates (Fig. 5e,f), the solubility product for K+A-(s) is no longer exceeded (for 
1500 mg/mL), and the compound completely dissolves above about pH 8, due to the increased solubility in 
alkaline solution. Figure 5e is an example of a mixed-charge dimer formation, AHA-, where the solubility 
Figure 5.  Simulations of various cases of free acid log S – pH curves where salt precipitates or where aggregates form 
(see text). 
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curve in the slope = 1 region shifts to lower pH values compared to that predicted by the Henderson-
Hasselbalch equation. In Figure 5f, an anionic trimer, A3
3-
, is indicated by the slope = 3 in the diagonal 
region of the log S profile.   
 
Example of a Step by Step Model Construction and Refinement for Ionizable Sparingly-Soluble Weak Acid 
     The following is a brief description of a practical process for developing and refining an equilibrium 
model to describe the solubility behavior of sparingly soluble drugs. 
1. Before starting to develop an equilibrium model for an ionizable molecule, it is first necessary to know 
the accurate value of the pKa. Preferably, the pKa is determined by an independent technique (e.g., by 
potentiometry, spectrophotometry, or capillary electrophoresis – but not by solubility).   
2. Plot the log S data as a function of pH. With an accurate pKa value at hand, the log S profile is 
inspected for its shape characteristics, to see if the profile resembles any of the template frames in 
Figure 5.   
3. If the pKa appears to be higher from the true value (as indicated by the pH in the middle of the bend in 
the log S curve), then either neutral aggregates form (Fig. 5d) or not enough time had been allowed 
for equilibrium to be reached. The pS0 can be estimated (for acids) as pS0
app + (pKa
app – pKa) [2]. Select 
H++A-  HA, HA  HA(s), and 2HA  A2H2 as the three equilibria to consider in the model, and 
associate pKa and pS0 with the first two equations. Take a guess on the third constant, e.g., assume it 
to be 3 (log units). Refinement will usually hone in on the appropriate value quickly enough if the 
equilibrium model is valid.   
4. If the pKa appears to be lower than the true value, but the slope in the diagonal portion of the log S 
profile is 1,  then a mixed-charge dimer (or higher order oligomer) may be present (cf., Fig 5e). The pS0 
can be estimated as solubility in the acidic region of the curve (pH << pKa). Select H
++A-  HA, HA  




 as the three equilibria to consider in the model, and associate pKa and pS0 
with the first two equations. Take a guess on the third constant, e.g., assume it to be 3 (log units).   
5. If the pKa appears to be slightly lower than the true value, but the slope in the diagonal portion of the 
log S profile is greater than 1, then an anionic oligomer may be present, with the degree of 
aggregation equal to the value of the slope (cf., Fig 5f). The pS0 can be estimated as solubility in the 
acidic region of the curve (pH << pKa). Select H
++A-  HA, HA  HA(s), and nA-  An
n- as the three 
equilibria to consider in the model, and associate pKa and pS0 with the first two equations. Take a 
guess on the third constant, e.g., assume it to be 3 (log units).   
6. It is possible that more than one mechanism is associated with the solubility profile. Therefore, a 
combination of the above steps may be needed. 
7. If the curve levels off in the alkaline solution (pH >> pKa), as in Figure 5, then a salt may have 
precipitated in alkaline solution.  It needs to be ascertained that the effect is not due to the complete 
dissolution of solid, as in Figures 5a,e,f. Enter the appropriate equilibrium expression along with a 
guess of the value of the constant. 
8. Having initial estimates of constants corresponding to proposed equilibrium reactions, the model is 
ready for weighted nonlinear regression, a procedure described elsewhere [2,6]. The iterative 
refinement will test the consistency between the data and the model.  If the agreement is not good 
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(root-mean square error >> 0.1), then the model may be modified and the refinement process 
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